El larguísimo trecho desde la ‘cura’ del cáncer en ratones hasta las personas La científica Laura Soucek, que eliminó tumores en roedores hace casi 20 años, invoca el “deber moral” de no generar falsas expectativas tras el anuncio de Mariano Barbacid

Enhorabuena @lsoucek.bsky.social y equipos en @vhio.bsky.social y #Peptomyc!!!
Convicción, perseverancia determinación y un durísimo esfuerzo (3 décadas) para llevar un resultado del laboratorio a ensayos clínicos. Con rigor y ética
#RoleModel
elpais.com/ciencia/2026...
@manuelansede.bsky.social

Very proud to be one of the Catalan awardees of the @erc.europa.eu Proof of Concept grants.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.

Frontiers | MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance Immunotherapies have transformed cancer treatment by harnessing the immune system to recognize and eliminate malignant cells, offering durable clinical benef...

New review just out in Frontiers in Immunology! 🎉

We dive into how #MYC reshapes the tumor–immune interface to drive #immuneescape and resistance to #immunotherapy.
Open access here 👉 www.frontiersin.org/journals/imm...
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc

Frontiers | MYC at the tumor–immune interface: mechanisms of immune escape and immunotherapy resistance Immunotherapies have transformed cancer treatment by harnessing the immune system to recognize and eliminate malignant cells, offering durable clinical benef...

New review just out in Frontiers in Immunology! 🎉

We dive into how #MYC reshapes the tumor–immune interface to drive #immuneescape and resistance to #immunotherapy.
Open access here 👉 www.frontiersin.org/journals/imm...
@vhio.bsky.social @icreacommunity.bsky.social @lsouceklab.bsky.social #peptomyc

Last week in San Francisco was intense, productive, and personally meaningful.

As CSO of #Peptomyc, , I joined our CEO @jesusmartingarcia.bsky.social during #JPMHealthcare week to meet with pharmaceutical companies and discuss potential strategic collaborations.
📍 San Francisco

Frontiers | The leading role of MYC in DNA damage response: exploring opportunities for therapeutic inhibition MYC performs a dual role in DNA Damage Response (DDR), promoting genomic instability through replication stress, R-loop formation, and topoisomerase-mediated...

Really happy to share our new open-access review in Frontiers in Cell and Developmental Biology 🎉
#MYC inhibition creates vulnerabilities that can be targeted with #DDR inhibitors.
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc @lsouceklab.bsky.social
www.frontiersin.org/journals/cel...

Laura, cada vez que vienes al @cniostopcancer.bsky.social descubrimos facetas nuevas de ti, de omomyc y de tu trayectoria como emprendedora. Eres un ejemplo y una inspiración para todos!
Estamos atentos a los ensayos clínicos de #Peptomyc!!!
@vhio.bsky.social

Honored to deliver a keynote today at the 19th Scientific Day & 29th Annual Conference of Vall d’Hebron on collaborative, challenge-driven research with transformative health impact. #MYC #OMO-103 #Omomyc
@vhio.bsky.social @icreacommunity.bsky.social #peptomyc

Ayer, 3 de diciembre, participé como ponente en la XV edición del @cniostopcancer.bsky.social Lab Day, contando mi experiencia científica y emprendedora en @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Muchas gracias a los estudiantes por invitarme! @msmelanoma.bsky.social

Huge thanks to Fabio Giuntini, and to the entire teams at
@vhio.bsky.social and #peptomyc for making this possible. We also want to acknowledge the support of
#AECMM and the @erc.europa.eu for backing research that can make a real difference.

Combinar el inhibidor de MYC Omomyc con terapias dirigidas a la reparación del ADN potencia la respuesta antitumoral en

Un estudio liderado por Laura Soucek y Fabio Giuntini muestra que combinar el inhibidor de MYC Omomyc (de #Peptomyc, VHIO y
@icreacommunity.bsky.social spin-off) con terapias dirigidas a la reparación del ADN potencia la actividad antitumoral en #cáncerdemamatriplenegativo
➡️ linke.to/OmomycVHIO_C...

MYC targeting by Omomyc synergizes with PARP inhibition and potentiates antitumor response in preclinical models of trip

🔴 A #VHIO-led study led by Laura Soucek and Fabio Giuntini shows that combining the MYC inhibitor #Omomyc (by VHIO & @icreacommunity.bsky.social's #Peptomyc) the with DNA-repair–targeted therapies boosts anti-tumor activity in preclinical triple-negative #BreastCancer.

➡️ linke.to/OmomycVHIO

Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.

Encantada de participar en el Ennova Health Day representando a @vhio.bsky.social, @icreacommunity.bsky.social y #Peptomyc. Gracias a la organización, #DiarioMédico y a los colegas de mesa por un debate inspirador. La innovación nace en y para el hospital.

Our news of the week: Poster presented at the first annual @sosclc-aecc.bsky.social Symposium, showcasing the work of Ana Lopez Garza and Hugo Thabussot on #SCLC research, conducted as part of the #AECC 70% Survivorship Challenge. @vhio.bsky.social #peptomyc

Mil gracias a la @fundacionfero.bsky.social por su invitación a impartir una Charla Científica en el Circulo Ecuestre y contar el desarrollo de nuestra terapia para el tratamiento del cáncer.
🙏🏻 Gracias FERO por vuestro apoyo continuo a la investigación contra el cáncer! @vhio.bsky.social #peptomyc

Honored to give the closing talk at the inaugural #GordonResearchConference (#GRC) on #Microproteins tomorrow in Castelldefels, Spain. Excited to share our latest work on developing a clinically viable MYC inhibitor and wrap up an incredible week of cutting-edge science. @vhio.bsky.social #peptomyc